For example, low absolute monocyte counts and high absolute eosinophil counts at baseline were associated with a favorable outcome in melanoma patients (n = 209) treated with anti-CTLA-4 (Martens et al. 2016). This evidence concerns the gene CTLA4 and melanoma.